Head-to-Head

Abbott Laboratories vs. Amneal Pharmaceuticals, Inc. Class A Common Stock

ABT

Abbott Laboratories

$109.29 -1.06%

VS AMRX

Amneal Pharmaceuticals, Inc. Class A Common Stock

$19.45 -2.51%

Abbott Laboratories (ABT) comes out ahead, leading on 2 of 2 compared factors.

Size & Scale

ABTAMRX
Market Cap $189.28 billion $6.95 billion

ABT leads on 1 of 1 size & scale factors.

Dividend

ABTAMRX
Dividend Yield 2.31% —

ABT and AMRX split the dividend factors evenly.

Risk & Sentiment

ABTAMRX
Short Interest 0.57% 2.39%

ABT leads on 1 of 1 risk & sentiment factors.

Dig deeper: ABT overview, ABT financials, AMRX overview, AMRX financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.